Article info

other Versions

PDF

Extended report
Sirukumab for rheumatoid arthritis: the phase III SIRROUND-D study

Authors

  1. Correspondence to Dr Paul P Tak, GlaxoSmithKline Research and Development, Stevenage SG1 2NY, UK; Paul-peter.x.tak{at}gsk.com
View Full Text

Citation

Takeuchi T, Thorne C, Karpouzas G, et al
Sirukumab for rheumatoid arthritis: the phase III SIRROUND-D study

Publication history

  • Received February 17, 2017
  • Revised July 11, 2017
  • Accepted July 18, 2017
  • First published August 30, 2017.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.